CALITHERA BIOSCIENCES INC (CALA) Financials

CALA Assets vs Liabilities

DateAssetsLiabilities
2022-12-31 28.7 million 8.3 million
2022-09-30 37.1 million 10.7 million
2022-06-30 45.6 million 10.3 million
2022-03-31 50.2 million 53.4 million

CALA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2022-12-31 -8.6 million 936000
2022-09-30 -7.7 million 939000
2022-06-30 -11.4 million 975000
2022-03-31 -16.0 million 1.2 million

CALA Net Income

No data available :(

CALA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2022-12-31 25.5 million - 1.7 million
2022-09-30 34.1 million - 2.0 million
2022-06-30 41.8 million - 2.4 million
2022-03-31 44.7 million - 2.7 million

CALA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2022-12-31 5.0 million
2022-09-30 4.9 million
2022-06-30 5.7 million
2022-03-31 3.9 million

CALA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2022-12-31 23000 4.8 million 2.6 million -
2022-09-30 110000 6.4 million 3.1 million -
2022-06-30 110000 7.8 million 3.6 million -
2022-03-31 110000 9.6 million 4.3 million -

CALA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2022-12-31 - -
2022-09-30 - -
2022-06-30 - -
2022-03-31 - -

CALA

Price: $0.02

52 week price:
0.01
0.50

Earnings Per Share: -7.94 USD

P/E Ratio: -3.31

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 883600

Ebitda: -6.6 million

Market Capitalization: 243625

Links: